[Development of sandwich ELISA for equine interferon-gamma detection].

This study focused on developing an Enzyme-Linked Immunosorbent Assay (ELISA) to quantitatively measure the presence of equine Interferon-gamma (IFN-gamma), a protein that plays a crucial role in immune response. The findings suggest that the developed ELISA could potentially provide insights into understanding the role of IFN-gamma in various equine diseases and aid in the development of specific cell-mediated immunity assays.

Method

• A Sandwich ELISA was developed, which is a specific type of ELISA used for detecting a substance in a sample.
• Monoclonal Antibody (mAb) A5 was used as a capture antibody. This served to ‘catch’ the specific substance (in this case, equine IFN-gamma).
• Biotinylated mAb SB10 was used as a detection antibody. This was added to the antibody-antigen complex, thereby acting as an indicator to confirm the existence of equine IFN-gamma in the sample. Biotinylating the detection antibody allows it to be recognized by an enzyme that produces a colour change, hence making detection possible.

Results & Outcomes

• The ELISA developed in the study was able to detect equine IFN-gamma at levels as low as 1 microgram per litre, demonstrating its sensitivity.
• No cross-reactivity was observed with recombinant equine Interleukin-18 (IL-18). This is crucial as it ensures the specificity of the ELISA: it reacts only with IFN-gamma and does not falsely detect IL-18 (another immune response-related protein).
• The ELISA could successfully detect equine IFN-gamma in the culture medium of Peripheral Blood Mononuclear Cells (PBMCs) stimulated with ConA or PMA/Ionomycin. These substances are commonly used to stimulate cells for the purpose of research.

Significance & Conclusion

• The development of this sensitive and specific ELISA for equine IFN-gamma enables researchers to measure the levels of this protein accurately.
• This, in turn, can aid in understanding IFN-gamma’s role in various equine diseases. For instance, increased levels detected may indicate an immune response to a disease, thereby providing diagnostic or therapeutic implications.
• Lastly, the data gathered using this ELISA can contribute to the development of cell-mediated immunity assays. These assays can help researchers to understand how the immune system responds at a cellular level, potentially opening new avenues for creating targeted therapies or designing vaccines for equine diseases.